163 related articles for article (PubMed ID: 19218588)
1. Aberrant DNA methylation status in human uterine leiomyoma.
Yamagata Y; Maekawa R; Asada H; Taketani T; Tamura I; Tamura H; Ogane J; Hattori N; Shiota K; Sugino N
Mol Hum Reprod; 2009 Apr; 15(4):259-67. PubMed ID: 19218588
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide DNA methylation analysis reveals a potential mechanism for the pathogenesis and development of uterine leiomyomas.
Maekawa R; Sato S; Yamagata Y; Asada H; Tamura I; Lee L; Okada M; Tamura H; Takaki E; Nakai A; Sugino N
PLoS One; 2013; 8(6):e66632. PubMed ID: 23818951
[TBL] [Abstract][Full Text] [Related]
3. Disease-dependent differently methylated regions (D-DMRs) of DNA are enriched on the X chromosome in uterine leiomyoma.
Maekawa R; Yagi S; Ohgane J; Yamagata Y; Asada H; Tamura I; Sugino N; Shiota K
J Reprod Dev; 2011 Oct; 57(5):604-12. PubMed ID: 21685710
[TBL] [Abstract][Full Text] [Related]
4. Potential mechanisms of aberrant DNA hypomethylation on the x chromosome in uterine leiomyomas.
Sato S; Maekawa R; Yamagata Y; Asada H; Tamura I; Lee L; Okada M; Tamura H; Sugino N
J Reprod Dev; 2014 Mar; 60(1):47-54. PubMed ID: 24291816
[TBL] [Abstract][Full Text] [Related]
5. DNA hypomethylation and imbalanced expression of DNA methyltransferases (DNMT1, 3A, and 3B) in human uterine leiomyoma.
Li S; Chiang TC; Richard-Davis G; Barrett JC; Mclachlan JA
Gynecol Oncol; 2003 Jul; 90(1):123-30. PubMed ID: 12821352
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma.
Navarro A; Yin P; Monsivais D; Lin SM; Du P; Wei JJ; Bulun SE
PLoS One; 2012; 7(3):e33284. PubMed ID: 22428009
[TBL] [Abstract][Full Text] [Related]
7. No evidence for the role of somatic mutations and promoter hypermethylation of FH gene in the tumorigenesis of nonsyndromic uterine leiomyomas.
Vaidya S; Shaik NA; Latha M; Chava S; Mohiuddin K; Yalla A; Rao KP; Kodati VL; Hasan Q
Tumour Biol; 2012 Oct; 33(5):1411-8. PubMed ID: 22528940
[TBL] [Abstract][Full Text] [Related]
8. Potential link between estrogen receptor-alpha gene hypomethylation and uterine fibroid formation.
Asada H; Yamagata Y; Taketani T; Matsuoka A; Tamura H; Hattori N; Ohgane J; Hattori N; Shiota K; Sugino N
Mol Hum Reprod; 2008 Sep; 14(9):539-45. PubMed ID: 18701604
[TBL] [Abstract][Full Text] [Related]
9. Identification of uterine leiomyoma-specific marker genes based on DNA methylation and their clinical application.
Sato S; Maekawa R; Yamagata Y; Tamura I; Lee L; Okada M; Jozaki K; Asada H; Tamura H; Sugino N
Sci Rep; 2016 Aug; 6():30652. PubMed ID: 27498619
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation and gene hypermethylation of the 14-3-3 gamma in uterine leiomyoma.
Jiang W; Luo H; Shen Z; Zhang W; Chen A; Zhu X
Front Biosci (Landmark Ed); 2016 Jun; 21(6):1286-95. PubMed ID: 27100507
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of erythropoietin in uterine leiomyoma: implications in tumor growth.
Asano R; Asai-Sato M; Miyagi Y; Mizushima T; Koyama-Sato M; Nagashima Y; Taguri M; Sakakibara H; Hirahara F; Miyagi E
Am J Obstet Gynecol; 2015 Aug; 213(2):199.e1-8. PubMed ID: 25724399
[TBL] [Abstract][Full Text] [Related]
12. Does aberrant DNA methylation occur in human uterine leiomyomas? An attempt of genome-wide screening by MS-RDA.
Cai LY; Izumi S; Abe M; Imura M; Yasugi T; Wakazono K; Ohnuki Y; Kondo A; Ushijima T
Tokai J Exp Clin Med; 2011 Sep; 36(3):84-90. PubMed ID: 21932190
[TBL] [Abstract][Full Text] [Related]
13. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.
Yatsenko SA; Mittal P; Wood-Trageser MA; Jones MW; Surti U; Edwards RP; Sood AK; Rajkovic A
Fertil Steril; 2017 Feb; 107(2):457-466.e9. PubMed ID: 27889101
[TBL] [Abstract][Full Text] [Related]
14. Epigenomic and enhancer dysregulation in uterine leiomyomas.
Mlodawska OW; Saini P; Parker JB; Wei JJ; Bulun SE; Simon MA; Chakravarti D
Hum Reprod Update; 2022 Jun; 28(4):518-547. PubMed ID: 35199155
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomas.
Sourla A; Polychronakos C; Zeng WR; Nepveu A; Kukuvitis A; Naud F; Koutsilieris M
Cancer Res; 1996 Jul; 56(13):3123-8. PubMed ID: 8674071
[TBL] [Abstract][Full Text] [Related]
16. The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development.
Yang Q; Mas A; Diamond MP; Al-Hendy A
Reprod Sci; 2016 Feb; 23(2):163-75. PubMed ID: 25922306
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450IA1 activity in human myometrium and uterine leiomyoma: influence of smoking.
Lamminen S; Pyykkö K; Rorarius M; Tuimala R
Toxicology; 1993 Oct; 83(1-3):41-8. PubMed ID: 8248949
[TBL] [Abstract][Full Text] [Related]
18. SATB2 and NGR1: potential upstream regulatory factors in uterine leiomyomas.
Sato S; Maekawa R; Tamura I; Shirafuta Y; Shinagawa M; Asada H; Taketani T; Tamura H; Sugino N
J Assist Reprod Genet; 2019 Nov; 36(11):2385-2397. PubMed ID: 31728810
[TBL] [Abstract][Full Text] [Related]
19. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
Schwetye KE; Pfeifer JD; Duncavage EJ
Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
[TBL] [Abstract][Full Text] [Related]
20. Comparative expression of thioredoxin-1 in uterine leiomyomas and myometrium.
Hou P; Zhao L; Li Y; Luo F; Wang S; Song J; Bai J
Mol Hum Reprod; 2014 Feb; 20(2):148-54. PubMed ID: 24130091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
